• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固有免疫和适应性免疫对 SARS-CoV-2 及相关影响因素。

Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.

机构信息

Tongji University School of Medicine, Tongji University, Shanghai, China.

Department of Epidemiology, Shanghai Key Laboratory of Medical Bioprotection, Key Laboratory of Biological Defense, Ministry of Education, Second Military Medical University, Shanghai, China.

出版信息

Front Immunol. 2023 May 9;14:1159326. doi: 10.3389/fimmu.2023.1159326. eCollection 2023.

DOI:10.3389/fimmu.2023.1159326
PMID:37228604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10203583/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), has affected all countries worldwide. Although some symptoms are relatively mild, others are still associated with severe and even fatal clinical outcomes. Innate and adaptive immunity are important for the control of SARS-CoV-2 infections, whereas a comprehensive characterization of the innate and adaptive immune response to COVID-19 is still lacking and the mechanisms underlying immune pathogenesis and host predisposing factors are still a matter of scientific debate. Here, the specific functions and kinetics of innate and adaptive immunity involved in SARS-CoV-2 recognition and resultant pathogenesis are discussed, as well as their immune memory for vaccinations, viral-mediated immune evasion, and the current and future immunotherapeutic agents. We also highlight host factors that contribute to infection, which may deepen the understanding of viral pathogenesis and help identify targeted therapies that attenuate severe disease and infection.

摘要

新型冠状病毒病(COVID-19)疫情由严重急性呼吸综合征冠状病毒(SARS-CoV-2)引起,已影响到全球所有国家。虽然一些症状相对较轻,但其他症状仍与严重甚至致命的临床结果相关。先天和适应性免疫对于控制 SARS-CoV-2 感染很重要,而对 COVID-19 的先天和适应性免疫反应的全面描述仍然缺乏,免疫发病机制和宿主易感性因素的机制仍然是科学争论的问题。在这里,讨论了先天免疫和适应性免疫在 SARS-CoV-2 识别和由此产生的发病机制中的特定功能和动力学,以及它们对疫苗接种的免疫记忆、病毒介导的免疫逃逸,以及当前和未来的免疫治疗药物。我们还强调了导致感染的宿主因素,这可能加深对病毒发病机制的理解,并有助于确定靶向治疗方法,以减轻严重疾病和感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a0/10203583/fa587aca3694/fimmu-14-1159326-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a0/10203583/84b97e294e19/fimmu-14-1159326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a0/10203583/6158d2bafe01/fimmu-14-1159326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a0/10203583/fa587aca3694/fimmu-14-1159326-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a0/10203583/84b97e294e19/fimmu-14-1159326-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a0/10203583/6158d2bafe01/fimmu-14-1159326-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b4a0/10203583/fa587aca3694/fimmu-14-1159326-g003.jpg

相似文献

1
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.固有免疫和适应性免疫对 SARS-CoV-2 及相关影响因素。
Front Immunol. 2023 May 9;14:1159326. doi: 10.3389/fimmu.2023.1159326. eCollection 2023.
2
Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.COVID-19 免疫发病机制中的树突状细胞:对其在决定疾病结局中可能起作用的深入了解。
Int Rev Immunol. 2021;40(1-2):108-125. doi: 10.1080/08830185.2020.1844195. Epub 2020 Nov 16.
3
The immune response to SARS-CoV-2 and COVID-19 immunopathology - Current perspectives.SARS-CoV-2 与 COVID-19 免疫病理的免疫反应——当前观点。
Pulmonology. 2021 Sep-Oct;27(5):423-437. doi: 10.1016/j.pulmoe.2021.03.008. Epub 2021 Apr 9.
4
Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.冠状病毒感染和新冠肺炎期间天然免疫在保护及发病机制中的作用
Annu Rev Immunol. 2024 Jun;42(1):615-645. doi: 10.1146/annurev-immunol-083122-043545.
5
A review on the immune responses against novel emerging coronavirus (SARS-CoV-2).新型冠状病毒(SARS-CoV-2)免疫反应综述。
Immunol Res. 2021 Jun;69(3):213-224. doi: 10.1007/s12026-021-09198-0. Epub 2021 Apr 29.
6
Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses.SARS-CoV-2 引起的全身性固有和适应性免疫反应与其他冠状病毒的关系。
Hum Vaccin Immunother. 2020 Dec 1;16(12):2980-2991. doi: 10.1080/21645515.2020.1802974. Epub 2020 Sep 2.
7
Immunity in SARS-CoV-2 Infection: Clarity or Mystery? A Broader Perspective in the Third Year of a Worldwide Pandemic.SARS-CoV-2 感染中的免疫:清晰还是神秘?在全球大流行的第三年的更广阔视角。
Arch Immunol Ther Exp (Warsz). 2023 Feb 21;71(1):7. doi: 10.1007/s00005-023-00673-0.
8
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
9
The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.严重急性呼吸综合征冠状病毒 2 感染对固有免疫的调节作用及抗击 COVID-19 炎症反应的治疗策略。
J Biomed Sci. 2022 May 3;29(1):27. doi: 10.1186/s12929-022-00811-4.
10
SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.SARS-CoV-2:致病机制与宿主免疫应答。
Adv Exp Med Biol. 2021;1313:99-134. doi: 10.1007/978-3-030-67452-6_6.

引用本文的文献

1
Kidney Involvement in SARS-CoV-2 Infection: Peritoneal Dialysis as the Preferred Modality.新型冠状病毒肺炎感染中的肾脏受累:腹膜透析作为首选治疗方式
Vaccines (Basel). 2025 Jul 2;13(7):723. doi: 10.3390/vaccines13070723.
2
A Review: Can Cytokines Induce Vascular Inflammation as a Sequela of Viral Infections?综述:细胞因子能否作为病毒感染的后遗症诱发血管炎症?
Health Sci Rep. 2025 Jul 21;8(7):e71105. doi: 10.1002/hsr2.71105. eCollection 2025 Jul.
3
Impact of Maternal Exposure to SARS-CoV-2 on Immunological Components of Breast Milk.

本文引用的文献

1
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.SARS-CoV-2 在长期 COVID-19 期间逃避细胞毒性 T 细胞。
Nat Commun. 2023 Jan 10;14(1):149. doi: 10.1038/s41467-022-34033-x.
2
The Spike protein of SARS-CoV-2 signals via Tlr2 in zebrafish.SARS-CoV-2 的刺突蛋白通过 Tlr2 在斑马鱼中发出信号。
Dev Comp Immunol. 2023 Mar;140:104626. doi: 10.1016/j.dci.2022.104626. Epub 2022 Dec 30.
3
Dynamics of Antibody and T Cell Immunity against SARS-CoV-2 Variants of Concern and the Impact of Booster Vaccinations in Previously Infected and Infection-Naïve Individuals.
母亲感染新型冠状病毒对母乳免疫成分的影响。
Int J Mol Sci. 2025 Mar 13;26(6):2600. doi: 10.3390/ijms26062600.
4
Epidemiology of SARS-CoV-2 Infection in Patients with Neuromuscular Disease and Inborn Errors of Metabolism: A Cross-sectional Study for a Pediatric Outpatient Referral in Japan.日本小儿门诊转诊患者中神经肌肉疾病和先天性代谢缺陷患者的新型冠状病毒2型感染流行病学:一项横断面研究
Kobe J Med Sci. 2025 Feb 3;70(4):E106-E112. doi: 10.24546/0100492945.
5
Contrasting Effects of SARS-CoV-2 Vaccination vs. Infection on Antibody and TCR Repertoires.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)疫苗接种与感染对抗体和T细胞受体库的对比效应
bioRxiv. 2023 Sep 11:2023.09.08.556703. doi: 10.1101/2023.09.08.556703.
6
Longitudinal transcriptional changes reveal genes from the natural killer cell-mediated cytotoxicity pathway as critical players underlying COVID-19 progression.纵向转录变化揭示了自然杀伤细胞介导的细胞毒性通路中的基因,这些基因是 COVID-19 进展的关键因素。
Elife. 2024 Oct 29;13:RP94242. doi: 10.7554/eLife.94242.
7
T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects.T 细胞肽预测、免疫反应以及接种疫苗和从轻度 COVID-19 中康复的受试者中的宿主-病原体关系。
Biomolecules. 2024 Sep 26;14(10):1217. doi: 10.3390/biom14101217.
8
Elevated serum mtDNA in COVID-19 patients is linked to SARS-CoV-2 envelope protein targeting mitochondrial VDAC1, inducing apoptosis and mtDNA release.COVID-19 患者血清中的 mtDNA 升高与 SARS-CoV-2 包膜蛋白靶向线粒体 VDAC1 有关,后者诱导细胞凋亡和 mtDNA 释放。
Apoptosis. 2024 Dec;29(11-12):2025-2046. doi: 10.1007/s10495-024-02025-5. Epub 2024 Oct 7.
9
SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination.严重急性呼吸综合征冠状病毒2(SARS-CoV-2):感染和疫苗接种引发的固有免疫反应一瞥
Antibodies (Basel). 2024 Feb 8;13(1):13. doi: 10.3390/antib13010013.
10
The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2.刺突蛋白的氨基酸取代和基因组重组对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进化的影响。
Front Microbiol. 2023 Jul 25;14:1228128. doi: 10.3389/fmicb.2023.1228128. eCollection 2023.
针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)关注变异株的抗体和T细胞免疫动力学以及加强疫苗接种对既往感染者和未感染者的影响
Vaccines (Basel). 2022 Dec 13;10(12):2132. doi: 10.3390/vaccines10122132.
4
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses.预先存在的交叉反应性免疫对 SARS-CoV-2 感染和疫苗反应的影响。
Nat Rev Immunol. 2023 May;23(5):304-316. doi: 10.1038/s41577-022-00809-x. Epub 2022 Dec 20.
5
Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2.分析针对呼吸病毒 SARS-CoV-2 疫苗引发的 B 细胞免疫应答。
Front Immunol. 2022 Nov 24;13:1058748. doi: 10.3389/fimmu.2022.1058748. eCollection 2022.
6
Small molecules in the treatment of COVID-19.小分子药物治疗 COVID-19。
Signal Transduct Target Ther. 2022 Dec 5;7(1):387. doi: 10.1038/s41392-022-01249-8.
7
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4 T cell recognition.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的突变会损害表位特异性CD4 T细胞识别。
Nat Immunol. 2022 Dec;23(12):1726-1734. doi: 10.1038/s41590-022-01351-7. Epub 2022 Dec 1.
8
Current understanding of T cell immunity against SARS-CoV-2.目前对T细胞针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)免疫反应的理解。
Inflamm Regen. 2022 Nov 29;42(1):51. doi: 10.1186/s41232-022-00242-6.
9
Differential activation of human neutrophils by SARS-CoV-2 variants of concern.SARS-CoV-2 关切变异株对人中性粒细胞的差异化激活。
Front Immunol. 2022 Oct 27;13:1010140. doi: 10.3389/fimmu.2022.1010140. eCollection 2022.
10
CD8 T-cell immune escape by SARS-CoV-2 variants of concern.SARS-CoV-2 关切变异株导致的 CD8 T 细胞免疫逃逸。
Front Immunol. 2022 Oct 27;13:962079. doi: 10.3389/fimmu.2022.962079. eCollection 2022.